Quick Answer
Sodium Hyaluronate Skin Hydration Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Skin hydration/elasticity improved sustainably for 3 months, with only 1.67% adverse events and no serious ones.
Key Takeaways
- 01Skin hydration/elasticity improved sustainably for 3 months, with only 1.67% adverse events and no serious ones. [Yang Rongya (2026)]
- 02This large-scale randomized controlled trial complements the existing evidence base for the novel sodium hyaluronate composite, strongly supporting its safty and clinical efficacy in facial rejuvenation through mesotherapy. [Yang Rongya (2026)]
- 03The GAIS score distribution demonstrated that within the treatment group, 5.57% of subjects were rated as “very much improved,” 41.11% as “much improved,” and 50.87% as “improved.” In contrast, only 6 subjects (3.95%) in the control group showed improvement of any degree, whereas the remainder were rated as “no change” or “worse” (Table). [Yang Rongya (2026)]
- 04Is this novel sodium hyaluronate composite containing 4 amino acids safe and effective for facial rejuvenation when administered via mesotherapy? [Yang Rongya (2026)]
The current Migaku evidence database contains 2 reusable source documents for Sodium Hyaluronate Skin Hydration Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Skin hydration/elasticity improved sustainably for 3 months, with only 1.67% adverse events and no serious ones. [Yang Rongya (2026); evidence level 2]
- This large-scale randomized controlled trial complements the existing evidence base for the novel sodium hyaluronate composite, strongly supporting its safty and clinical efficacy in facial rejuvenation through mesotherapy. [Yang Rongya (2026); evidence level 2]
- The GAIS score distribution demonstrated that within the treatment group, 5.57% of subjects were rated as “very much improved,” 41.11% as “much improved,” and 50.87% as “improved.” In contrast, only 6 subjects (3.95%) in the control group showed improvement of any degree, whereas the remainder were rated as “no change” or “worse” (Table). [Yang Rongya (2026); evidence level 2]
- Is this novel sodium hyaluronate composite containing 4 amino acids safe and effective for facial rejuvenation when administered via mesotherapy? [Yang Rongya (2026); evidence level 2]
- Objective This study aimed to determine whether liposomal delivery enhances the effects of a collagen tripeptide-containing formulation on dermal structural and biomechanical parameters, as well as appearance-related skin properties, compared with a nonliposomal formulation and placebo. [Lin YK (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Efficacy and Safety of a Novel Sodium Hyaluronate Composite Solution via Mesotherapy for Facial Rejuvenation: A Multicenter Randomized Controlled Study
- Liposomal Delivery Enhances the Effects of a Collagen Tripeptide-Containing Formulation on Dermal Structure and Optical Skin Parameters: A Randomized, Double-Blind, Placebo-Controlled Trial.